Use of Low-Level Laser Therapy as Monotherapy or Concomitant Therapy for Male and Female Androgenetic Alopecia

The study evaluated the use of low-level laser therapy (LLLT) for androgenetic alopecia (AGA) in male and female patients, either as monotherapy or as concomitant therapy with minoxidil or finasteride. The study involved 32 patients, and improvement was observed both with monotherapy and with concomitant therapy. Improvement was seen as early as 3 months and was sustained up to a maximum observation time of 24 months. No adverse reactions were reported. The study concluded that LLLT represents a potentially effective treatment for both male and female AGA, either as monotherapy or concomitant therapy.